Cue Growth is a New York-based healthcare investment firm backing U.S. growth opportunities in innovative medical devices, healthcare technology, biotechnology and related services. The firm makes later-stage venture, growth equity and buyout investments, including minority growth investments and control buyouts, and has acted as a co-lead investor. It can build up to $50 million of equity, making it relevant for healthcare companies seeking expansion capital or buyout-oriented backing.